Your browser doesn't support javascript.
loading
Patient-reported outcomes in moderate-to-severe allergic asthmatics treated with omalizumab: a systematic literature review of randomized controlled trials.
Corren, Jonathan; Kavati, Abhishek; Ortiz, Benjamin; Vegesna, Ashok; Colby, Jennifer A; Ruiz, Kimberly; Panettieri, Reynold A.
Affiliation
  • Corren J; a David Geffen School of Medicine at UCLA , Los Angeles , CA , USA.
  • Kavati A; b Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.
  • Ortiz B; b Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.
  • Vegesna A; b Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.
  • Colby JA; c Xcenda, LLC , Palm Harbor , FL , USA.
  • Ruiz K; c Xcenda, LLC , Palm Harbor , FL , USA.
  • Panettieri RA; d Rutgers, The State University of New Jersey, Rutgers Institute for Translational Medicine and Science , New Brunswick , NJ , USA.
Curr Med Res Opin ; 34(1): 65-80, 2018 01.
Article in En | MEDLINE | ID: mdl-29057669
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Omalizumab / Patient Reported Outcome Measures Type of study: Clinical_trials / Systematic_reviews Aspects: Patient_preference Limits: Adolescent / Adult / Child / Humans Language: En Journal: Curr Med Res Opin Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Omalizumab / Patient Reported Outcome Measures Type of study: Clinical_trials / Systematic_reviews Aspects: Patient_preference Limits: Adolescent / Adult / Child / Humans Language: En Journal: Curr Med Res Opin Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom